Skip to main content
 CHANGE IN VISITATION GUIDELINES: Please read before visiting Rutgers Cancer Institute.
Menu

Researcher Publications

Tina M. Mayer, MD

Selected Publications

  • Srivastava A, Rivera‐Núñez Z, Kim S, Sterling J, Farber N, Radadia K, Patel H, Modi P, Goyal S, Parikh R, Mayer T, Saraiya B, Sadimin E, Weiss R, Kim I, Elsamra S, Jang T, Singer E. Impact of pathologic lymph node–positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer. 2020. Cancer, 126(9); epub ahead of print 14 April 2020
  • Bitting R, Healy P, George D, Anand M, Kim S, Mayer T, Winters C, Riggan C, Rasmussen J, Wilder R, Stein MS, Frizzell B, Harrison M, Zhang T, Lee W, Wu Y, Koontz B, Armstrong A. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. European Urology Oncology. Accepted Jan 2020
  • Tabakin AL, Shinder BM, Kim S, Rivera-Nunez Z, Polotti CF, Modi PK, Sterling JA, Farber NJ, Radadia KD, Parikh RR, Kim IY, Saraiya B, Mayer TM, Singer EA, Jang TL. Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014. Clin Genitourin Cancer, 10(2): e194-e201, 2020
  • Munshi F, Shinder B, Sadimin E, Mayer T, Singer E; Metastatic Prostate Cancer to the Renal Pelvis and Proximal Ureter: A Case Report and Review of the Literature; Cancer Studies and Therapeutics, 4(4): 1-4, 2019
  • Portal DE*, Weiss RE*, Wojtowicz M, Mansour A, Monken C, Mehnert JM, Aisner JA, Kane M, Nishioka J, Aisner S, Peters S, Stein MN, Kim IY, Mayer TM, Shih W, Gulley J, Streicher H, Singer EA, Lattime EC. Phase I neoadjuvant study of intravesical recombinant Fowlpox-GM-CSF (rFGMCSF) or Fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinoma. Cancer Gene Therapy, published online 20 June 2019.
  • Stein M, Malhotra J, Tarapore R, Malhotra U, Silk A, Chan N, Rodriguez L, Aisner J, Aiken R, Mayer T, Haffty B, Newman J, Aspromonte S, Bommareddy P, Estupinian R, Chesson S, Sadimin E, Li S, Medina D, Saunders T, Frankel M, Kareddula A, Damare S, Wesolowsky E, Gabel C, El-Deiry W, Prabhu V, Allen J, Stogniew M, Oster W, Bertino J, Libutti S, Mehnert J, Zloza A; Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration; Journal for ImmunoTherapy of Cancer, published online 22 May 2019
  • Radadia K, Farber N, Tabakin A, Wang W, Patel HV, Polotti C, Weiss RE, Elsamra SE, Kim IY, Singer EA, Stein MN, Mayer TM, Jang TL; Effect of Alvimopan on gastrointestinal recovery and hospital length of stay after retroperitoneal lymph node dissection for testicular cancer; Journal of Clinical Urology, 12:122-128, 2019
  • Tabakin Al, Sadimin ET, Tereshchenko I, Kareddula A, Stein MN, Mayer T, Hirshfield KM, Kim IY, Tischfield J, DiPaola RS, Singer EA; Correlation of prostate cancer CHD1 status with response to androgen deprivation therapy: a pilot study; J Genitourin Disord, 2: pii: 1006, 2018
  • Farber NJ, Rivera-Nunez Z, Kim S, Shinder B, Radadia K, Sterling J, Modi PK, Goyal S, Parikh R, Mayer TM, Weiss RE, Kim IY, Elsamra SE, Jang TL, Singer EA; Trends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National Cancer Database; Urol Oncol, 37:26-32, 2018
  • Panda A, de Cubas A, Stein M, Riedlinger G, Kra J, Mayer T, Smith CC, Vincent BG, Serody JS, Beckermann KE, Ganesan S, Bhanot G, Rathmell K; Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma; JCI Insight, 3: pii:121522, 2018
  • Paller CJ, Zhou XC, Heath EI, Taplin ME, Mayer T, Stein MN, Bubley GJ, Pili R, Hudson T, Kakarla R, Abbas MM, Anders NM, Dowling D, King S, Bruns AB, Wagner WD, Drake CG, Antonarakis ES, Eisenberger MA, Denmeade SR, Rudek MA, Rosner GL, Carducci MA; Muscadine grape skin extract (MPX) in men with biochemically recurrent prostate cancer: a randomized, multicenter, placebo-controlled clinical trial; Clin Cancer Res, 24: 306-315, 2018
  • Gorshein E, Burger R, Ferrari A, Mayer T; Dramatic mixed response of lymphangitic pulmonary metastatses in newly diagnosed prostate cancer; Urol Ann, 9:278-280, 2017
  • Stein MN, Bertino JR, Kaufman HL, Mayer T, Moss R, Silk A, Chan N, Malhotra J, Rodriguez L, Aisner J, Aiken RD, Haffty BG, DiPaola RS, Saunders T, Zloza A, Samra S, Becektt Y, Yu B, Najmi S, Gabel C, Dickerson S, Zheng L, El-deiry WS, Allen JE, Stogniew M, Oster W, Mehnert JM; First-in-human clinical trial of oral ONC201 in patients with refractory solid tumors; Clin Cancer Res, 23:4163-4169, 2017
  • Shinder B, Farber NJ, Mayer TM, Singer EA; Treatment of multifocal renal cell carcinoma in a solitary kidney with nivolumab; Clinical Genitourinary Cancer, 15:e165-167, 2017
  • Kim S, Patel AN, Nelson C, Shen S, Mayer T, Moore DF, Lu-Yao GL; Does certificate of need minimize intensity modulated radiation therapy use in low risk prostate cancer?; Urology Practice, 3:342-348, 2016
  • Chao HH, Mayer T, Concato J, Rose Mg, Uchio E, Kelly WK ; Prostate cancer, comorbidity, and participation in randomized controlled trials of therapy; J Investig Med, 58:566-8, 2010

Abstracts (all peer reviewed):

  • Popli P, Shah M, Ralefala T, Toppmeyer D, Strair R, Lebelonyane R, Mompe A, Gaolathe T, Antony R, Marlink R, Mayer T. Reducing Oncologic Disparities by Standardizing Cancer Care; Annual Symposium on Global Cancer Research, 2020, Accepted for Poster, Abstract 65, Washington, DC
  • Shinder B, Kim S, Srivastava A, Patel HV, Mayer TM, Saraiya B, Singer EA; Factors associated with clinical trial participation for patients with renal cell carcinoma; GU ASCO, 2020; Abstract 670, San Francisco, CA
  • Srivastava A, Rivera-Nunez Z, Kim S, Sterling J, Farber N, Radadia K, Modi P, Goyal S, Mayer T, Saraiya B, Weiss R, Kim I, Elsamra S, Jang T, Singer E. Impact of pathologic node positive renal cell carcinoma on survival in patients without metastasis: evidence in support of expanding the definition of stage IV kidney cancer; SUO Society of Urologic Oncology, 2019, Abstract 201, Washington, DC
  • Liu G, Kyriakopoulous C, Lang J, Sperger J, Singh A, Heath E, Perlman S, Mayer T, Modelska K, Porcari A, Duggan W, Jeraj R; Spatial-temporal change in quantitative total bone imaging (QTBI) and circulating tumor cells (CTCs) in metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide (ENZA); ESMO, 2019; Abstract 2226, Barcelona, Spain
  • Chandar A, Kaur S, Ralefala T, Toppmeyer D, Strair R, Philipp C, Marlink R, Antony R, DiGiacobbe M, Lebelonyane R, Goalathe T, Mayer T; Building international partnerships to improve global oncological care: perspective from Rutgers-CINJ global oncology fellowship program; ASCO Quality Care Symposium, 2019; Abstract 159
  • Chandar A, Kaur S, Toppmeyer D, Ralefala T, Strair R, Philipp C, Marlink R, Antony R, DiGiacobbe M, Lebelonyane R, Goalathe T, Mayer T; Building international partnerships to improve global oncological care: perspective from Rutgers-CINJ global oncology fellowship program; ASCO, 2019; Abstract e18161
  • Kaur S, Chandar A, Mayer T, Toppmeyer D, Strair R, Marlink R, Antony R, DiGiacobbe M, Lebelonyane R, Goalathe T, Ralefala T; Evaluating the challenges of cancer care in Botswana: Chemotherapy utilization and stock outs; ASCO 2019; Abstract e18309

Return to member profile